Olink Proteomics AB.png
Olink reports third quarter 2023 financial results
November 15, 2023 07:00 ET | Olink Proteomics AB
UPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023. ...
Olink Proteomics AB.png
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
November 05, 2023 20:00 ET | Olink Proteomics AB
Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.
Olink Proteomics AB.png
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
October 05, 2023 16:25 ET | Olink Proteomics AB
Three landmark studies published in Nature demonstrate the power of Olink technology for understanding human biology.
Olink Proteomics AB.png
Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
September 19, 2023 03:00 ET | Olink Proteomics AB
Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. ...
Olink Proteomics AB.png
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
September 12, 2023 11:00 ET | Olink Proteomics AB
Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12th...
Olink Proteomics AB.png
Olink to participate in September investor events
August 29, 2023 08:00 ET | Olink Proteomics AB
UPPSALA, Sweden, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: ...
Olink Proteomics AB.png
Olink reports second quarter 2023 financial results
August 09, 2023 07:00 ET | Olink Proteomics AB
UPPSALA, Sweden, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023. ...
Olink Proteomics AB.png
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform
August 08, 2023 08:00 ET | Olink Proteomics AB
UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has...
Olink Proteomics AB.png
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
July 13, 2023 08:00 ET | Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...
Olink Proteomics AB.png
Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference
July 13, 2023 08:00 ET | Olink Proteomics AB
UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market...